Technical Analysis for MNMD - Mind Medicine (MindMed) Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Earnings Movers | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Earnings Movers | Other | -2.54% | |
Wide Bands | Range Expansion | -2.54% | |
Down 3 Days in a Row | Weakness | -2.54% | |
Stochastic Reached Overbought | Strength | -3.15% | |
Inside Day | Range Contraction | -3.15% | |
Wide Bands | Range Expansion | -3.15% |
Alert | Time |
---|---|
Down 2 % | about 19 hours ago |
Down 1% | about 19 hours ago |
Rose Above Previous Day's High | about 22 hours ago |
10 DMA Resistance | about 22 hours ago |
Up 2% | about 22 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/31/2024
Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Drug Development Psychoactive Drugs Entheogens Psychedelic Drug N Dimethyltryptamine
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Drug Development Psychoactive Drugs Entheogens Psychedelic Drug N Dimethyltryptamine
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 12.22 |
52 Week Low | 2.41 |
Average Volume | 696,119 |
200-Day Moving Average | 7.20 |
50-Day Moving Average | 5.99 |
20-Day Moving Average | 6.03 |
10-Day Moving Average | 6.31 |
Average True Range | 0.34 |
RSI (14) | 50.25 |
ADX | 24.33 |
+DI | 22.17 |
-DI | 16.68 |
Chandelier Exit (Long, 3 ATRs) | 5.74 |
Chandelier Exit (Short, 3 ATRs) | 6.06 |
Upper Bollinger Bands | 7.01 |
Lower Bollinger Band | 5.06 |
Percent B (%b) | 0.56 |
BandWidth | 32.25 |
MACD Line | 0.10 |
MACD Signal Line | 0.08 |
MACD Histogram | 0.0226 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 6.67 | ||||
Resistance 3 (R3) | 6.70 | 6.57 | 6.58 | ||
Resistance 2 (R2) | 6.57 | 6.43 | 6.55 | 6.55 | |
Resistance 1 (R1) | 6.35 | 6.35 | 6.29 | 6.32 | 6.52 |
Pivot Point | 6.22 | 6.22 | 6.18 | 6.20 | 6.22 |
Support 1 (S1) | 6.00 | 6.08 | 5.94 | 5.97 | 5.76 |
Support 2 (S2) | 5.87 | 6.00 | 5.85 | 5.73 | |
Support 3 (S3) | 5.65 | 5.87 | 5.70 | ||
Support 4 (S4) | 5.62 |